Letter to Editor
Although the causes of rheumatic diseases have remained relatively unknown, systemic intracellular bacterial infections are commonly found in rheumatic disease patients [1] [2] [3] [4] .
Because of this, certain infections have been confused with comorbid conditions.
Often patients with rheumatic diseases have co-morbidities, and some authors have concluded that this can include chronic infections. "Infections continue to be a signifi cant cause of morbidity and mortality in patients with rheumatic diseases, and, consequently, early diagnosis and treatment of infection is critical to the successful medical management of these patients" [5] .
A link between certain types of infections and rheumatic diseases has been seen by a number of authors. For example, infections with Mycoplasma species, Borrelia species and other intracellular bacteria have been linked to various forms of rheumatic disease [1] [2] [3] [4] [6] [7] [8] [9] [10] [11] [12] [13] . In addition, animal models of rheumatic disease have been established by infection with Mycoplasma species [13] [14] [15] . In one of these contributions experimental arthritis was induced by a clinical isolate from M.
fermentans injected into the joints of rabbits [15] . Outbreaks of rheumatic disease, such as polyarthritis, have been traced to infections by Mycoplasma species [16] . Arthritis in animals caused by Mycoplasma species infections closely resemble the signs and symptoms found in patients with rheumatoid arthritis [17] . In addition, reactive arthritis following M. pneumonia infection has been seen in patients [18] . Mycoplasma infections have also been found in the joints of patients with rheumatic disease [19] [20] [21] .
In a case-control study the presence of antibodies against Mycoplasma pneumoniae have been statistically correlated to the clinical features of rheumatoid arthritis (p<0.001) [21] . Furthermore, genetic analyses and transmission in animals indicate that arthritis is not directly linked to genetic abnormalities [22] showed greater improvements in joint swelling and tenderness (p<0.02), and the treatment group also had better improvements in hematocrit, SED rate, platelet counts and rheumatoid factor with no serious toxicity [27, 28] . A 4-year follow-up indicated that the minocycline-treated patients had fewer relapses and less frequent need for immune-suppressive drugs to control their RA (p<0.02) [29] . Although treatment of arthritis with antibiotics was effective and safe, treatment failures can, just as in any treatment for arthritis, be due to therapeutic failures, resistance and/or mutation of the microorganism [30] . 
